<DOC>
	<DOCNO>NCT01817504</DOCNO>
	<brief_summary>Our hypothesis early systematic transplantectomy well-conducted immunosuppression associate decreased risk anti-HLA immunization conservative attitude include gradual reduction immunosuppression , without transplantectomy perform cause ( clinical event ) . Observation Investigation Method Used : The study : - multicenter - prospective - open - randomize : patient divide two parallel group : - study group : transplantectomy within six week return dialysis , antiproliferatives stop start dialysis , Maintenance anticalcineurin-based-immunosuppression without dose reduction two week transplantectomy . Abrupt discontinuation anticalcineurin two week transplantectomy . Corticosteroids : 5mg per day one month transplantectomy stop within one month . - control group : No systematic transplantectomy . Antiproliferatives stop start dialysis.Anticalcineurins half dose 3 month , ¼ dose 3 month stop . Corticosteroids:5 mg per day 6 month , taper stop within 3 month . In case transplantectomy cause control group , immunosuppression continue maintenance dose current surgical procedure , withdrawn two week later , similary systematic transplantectomy .</brief_summary>
	<brief_title>Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure</brief_title>
	<detailed_description />
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<criteria>Age ≥ 18 Years . Patients affiliate health protection system , social security France similar regimen . Renal transplant patient endstage transplantation , regardless number previous transplant . Patient receive immunosuppressive protocol base anticalcineurin mTOR inhibitor Patient resume hemodialysis within 4 week Duration transplantation one year Patient asymptomatic graft immunogenic potential residual &gt; 50 % ( calculated PIR redialysis ) Patient cover measure legal protection . Immunogenic potential residual &lt; 50 % Graft infection uncontrolled treatment Active infectious pathology Inflammatory graft Uncontrolled arterial hypertention Inflammatory syndrome undetermined origin CRP &gt; 50mg/l Fever unknown origin 8 day T &gt; 38°C Contraindication surgery AVK treatment Patient candidate living donor within 12 month Monotherapy calcineurin inhibitor mTOR inhibitor Treatment direct humoral response 6 month precede recovery dialysis ( Rituximab IVIg high dos ) Presence another transplant ( pancreas , liver , heart , lung )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Renal failure ,</keyword>
	<keyword>Transplantectomy</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Sensitization</keyword>
</DOC>